COVID-19 and drug shortages: A call to action

Andrew G. Shuman, Erin R. Fox, Yoram Unguru

Research output: Contribution to journalReview articlepeer-review

Abstract

The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients.

Original languageEnglish (US)
Pages (from-to)945-947
Number of pages3
JournalJournal of Managed Care and Specialty Pharmacy
Volume26
Issue number8
DOIs
StatePublished - Aug 1 2020

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science
  • Health Policy

Fingerprint Dive into the research topics of 'COVID-19 and drug shortages: A call to action'. Together they form a unique fingerprint.

Cite this